Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

QURE

uniQure NV

47.51

Jun 26 • 04:00PM ET -1.59 (-3.24%)

Healthcare Biotechnology Netherlands Mid NASD

Peers: BEAM NTLA CRSP EDIT VIR BMRN RYTM IONS ALNY INCY

| Held by: XBI VXF IBB SCHA JGRO ITOT KOMP VHT LABU GNOM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.51	Insider Own	9.80%	Shs Outstand	63.03M	Perf Week	2.64%
Market Cap	2.97B	Forward P/E	-	EPS next Y	-3.07	Insider Trans	-7.52%	Shs Float	56.40M	Perf Month	88.76%
Enterprise Value	2.93B	PEG	-	EPS next Q	-0.84	Inst Own	90.07%	Short Float	20.93%	Perf Quarter	204.55%
Income	-208.87M	P/S	164.22	EPS this Y	-5.94%	Inst Trans	-5.74%	Short Ratio	5.57	Perf Half Y	96.48%
Sales	18.09M	P/B	20.05	EPS next Y	16.30%	ROA	-30.18%	Short Interest	11.81M	Perf YTD	98.54%
Book/sh	2.37	P/C	5.06	EPS next 5Y	18.21%	ROE	-228.24%	52W High	71.50 -33.55%	Perf Year	233.87%
Cash/sh	9.38	P/FCF	-	EPS past 3/5Y	-8.45% -4.24%	ROIC	-30.18%	52W Low	8.73 444.22%	Perf 3Y	314.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-46.73% -15.57%	Gross Margin	17.67%	Volatility	7.92% 7.67%	Perf 5Y	53.56%
Dividend TTM	-	EV/Sales	161.96	EPS Y/Y TTM	19.99%	Oper. Margin	-1082.08%	ATR (14)	3.48	Perf 10Y	542.90%
Dividend Ex-Date	-	Quick Ratio	10.40	Sales Y/Y TTM	-10.44%	Profit Margin	-1154.42%	RSI (14)	73.24	Recom	1.36
Dividend Gr. 3/5Y	- -	Current Ratio	10.40	EPS Q/Q	-3.85%	SMA20	37.57%	Beta	0.78	Target Price	62.33
Payout	-	Debt/Eq	3.65	Sales Q/Q	127.31%	SMA50	74.51%	Rel Volume	1.49	Prev Close	49.10
Employees	221	LT Debt/Eq	3.63	Earnings	May 05 BMO	SMA200	67.97%	Avg Volume	2.12M	Price	47.51
IPO	Feb 05, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.71% -31.56%	Trades		Volume	3,150,803	Change	-3.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)